Search
>
News_Details

Qijian has made new progress in the R&D of high-efficiency hGH and long-acting hGH

Author:
Source:
2021/05/12 17:33
Page view

  Drug innovation is related to the innovation and development of China’s pharmaceutical industry, to the international competitiveness of China’s pharmaceutical industry, to the protection of public health rights and interests, and to the availability and accessibility of public drugs. In recent years, Qijian has been committed to the drug, according to the market demand, after continuous efforts, our R&D team is investigating the development of a new type of highly effective growth hormone and long-acting growth hormone, these two kinds of growth hormone have super long acting time, to solve the existing growth hormone need to be injected within a fixed time, to provide a better treatment plan for the majority of patients. These two kinds of HGH have similar efficacy to powder HGH, and are naturally structured growth hormone, which is consistent with the human body’s own secretion of growth hormone.

  It is well known that human growth hormone (HGH) is an essential therapeutic agent for growth hormone deficiency. Human Growth Hormone (HGH) is a peptide hormone produced by the anterior pituitary gland. It is composed of 191 amino acids and promotes bone, visceral and systemic. It plays a key role in human growth and development by promoting protein synthesis and influencing metabolism of fats and minerals.

  In general, growth hormone is the abbreviation of recombinant growth hormone(Somatropin), is produced by the gene recombinant escherichia coli secretory expression technology, in the amino acid content sequence and protein structure is completely consistent with human pituitary growth hormone.

  

Next article: